Richard Kones Selected Research

Therapeutics

7/2017	Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation.
1/2016	Stable Ischemic Heart Disease.
7/2015	Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies.
10/2014	Exclusion of 'nonRCT evidence' in guidelines for chronic diseases - is it always appropriate? The Look AHEAD study.
8/2014	Stable ischemic heart disease.
1/2013	Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.
11/2011	Oxygen therapy for acute myocardial infarction-then and now. A century of uncertainty.
9/2010	Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.
1/2010	Mitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifying.
8/2009	The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard Kones Research Topics

Disease

4	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 08/2009
4	Inflammation (Inflammations) 06/2014 - 08/2010
3	Obesity 11/2017 - 01/2011
3	Disease Progression 01/2016 - 01/2011
3	Weight Loss (Weight Reduction) 03/2014 - 10/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2014 - 01/2013
3	Myocardial Infarction 11/2011 - 08/2009
3	Acute Coronary Syndrome 11/2011 - 08/2010
2	Hypertension (High Blood Pressure) 07/2017 - 01/2013
2	Chronic Disease (Chronic Diseases) 01/2017 - 10/2014
2	Dyslipidemias (Dyslipidemia) 07/2015 - 07/2015
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 07/2015 - 06/2013
2	Ischemia 11/2011 - 09/2010
2	Coronary Disease (Coronary Heart Disease) 11/2011 - 01/2011
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2010 - 08/2010
2	Stable Angina 09/2010 - 08/2010
2	Parkinson Disease (Parkinson's Disease) 08/2010 - 01/2010
1	Muscular Atrophy (Muscle Atrophy) 01/2018
1	Heart Diseases (Heart Disease) 07/2015
1	Hypertriglyceridemia 07/2015
1	Autoimmune Diseases (Autoimmune Disease) 01/2013
1	Thrombosis (Thrombus) 01/2013
1	Atherosclerosis 01/2013
1	Infarction (Infarctions) 11/2011
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2010
1	Unstable Angina 08/2009
1	Stroke (Strokes) 08/2009

Drug/Important Bio-Agent (IBA)

5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2015 - 08/2009
3	Rosuvastatin Calcium (Crestor)FDA Link 01/2011 - 08/2009
2	Proteins (Proteins, Gene)FDA Link 03/2014 - 08/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013 - 08/2010
2	LDL CholesterolIBA 01/2013 - 01/2011
2	Oxygen (Dioxygen)IBA 11/2011 - 08/2010
2	oxidized low density lipoproteinIBA 01/2011 - 08/2009
1	isocaproic acidIBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 07/2017
1	Antihypertensive Agents (Antihypertensives)IBA 07/2017
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2017
1	mipomersenIBA 07/2015
1	Fibric Acids (Fibrates)IBA 07/2015
1	BMS201038IBA 07/2015
1	Biomarkers (Surrogate Marker)IBA 06/2014
1	CarbohydratesIBA 03/2014
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 07/2013
1	Cholesterol Ester Transfer ProteinsIBA 01/2013
1	Triglycerides (Triacylglycerol)IBA 01/2013
1	evacetrapibIBA 01/2013
1	anacetrapibIBA 01/2013
1	LipidsIBA 01/2011
1	Glucose (Dextrose)FDA LinkGeneric 01/2011
1	C-Reactive ProteinIBA 12/2010
1	CalciumIBA 09/2010
1	Ranolazine FDA Link 09/2010
1	alpha-SynucleinIBA 08/2010
1	UbiquitinIBA 08/2010
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2010
1	CytokinesIBA 08/2010
1	Dopamine (Intropin)FDA LinkGeneric 01/2010

Therapy/Procedure

10	Therapeutics 07/2017 - 08/2009
3	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 03/2014 - 10/2010
1	Caloric Restriction 11/2017
1	Polypharmacy 01/2017
1	Drug Therapy (Chemotherapy) 06/2013
1	Patient Readmission 01/2013
1	Percutaneous Coronary Intervention 09/2010